Healthcare

in committee · New Jersey · General Assembly Jan 13, 2026

A 3265: Establishes certain prescription drug data reporting requirements for hospitals.

This bill requires New Jersey hospitals to report prescription drug pricing data to the Division of Consumer Affairs. It mandates hospitals (defined as general acute care hospitals licensed under state law) to submit accurate data on drug costs, including wholesale acquisition cost, under penalty of perjury. Non-compliance could result in civil penalties starting at $10,000 for the first day of violation and increasing up to $100,000 per day. The law also authorizes audits and corrective action plans for reporting deficiencies. This directly affects hospitals and other entities required to report drug pricing data under the amended statute.

Topics ✓ HealthcareSupports HealthcareMandates drug pricing transparency to improve cost oversight, potentially lowering patient costs and enhancing access to medications.85% confidence

Sub-Topics Prescription Drugs

Track

in committee · New Jersey · General Assembly Feb 19, 2026

A 4336: Requires menopause informational pamphlet to be distributed under certain circumstances.

This bill (A4336) requires licensed healthcare providers to give a menopause information pamphlet to female patients aged 35-39 during their annual physical exams, starting 180 days after the law takes effect. The pamphlet, created by the New Jersey Department of Health within 90 days of the law's effective date, covers premature menopause, early menopause, and primary ovarian insufficiency. It aims to provide standardized educational resources during routine healthcare visits for this age group. The bill directly affects healthcare providers conducting these exams and female patients in the specified age range.

Topics ✓ HealthcareSupports HealthcareRequires healthcare providers to distribute standardized menopause education during routine visits, improving patient access to health information and advancing preventive care standards.95% confidence

Track

died · New Jersey · General Assembly Jan 13, 2026

A 1526: Establishes Psilocybin Behavioral Health Access and Therapy Pilot Program; appropriates $6 million.

This bill establishes a $6 million pilot program to study psilocybin therapy for behavioral health conditions like depression and anxiety through New Jersey hospitals. It directs the Department of Health to select participating hospitals across three regions (Central, Northern, Southern) to conduct FDA- and DEA-compliant research, with oversight from a new advisory board. The program aims to evaluate whether a future statewide system for safe, legal psilocybin therapy could be developed, focusing on treatment-resistant depression and other conditions. The bill was withdrawn after being approved as part of P.L.2025, c.296, meaning it is now law but no longer pending.

Topics ✓ HealthcareSupports HealthcareFunds $6M pilot program for psilocybin therapy research to treat depression/anxiety, advancing mental health treatment access and expanding behavioral health services.95% confidence

Sub-Topics Mental Health

Track

in committee · New Jersey · General Assembly Jan 13, 2026

A 3131: Requires labeling of over-the-counter and prescription drugs containing major food allergen or gluten-containing grain.

This bill requires all over-the-counter and prescription drugs containing ingredients derived from common food allergens (like peanuts or shellfish) or gluten-containing grains (like wheat) to display clear, visible labels identifying those specific ingredients. It directly affects drug manufacturers and pharmacies by mandating this labeling on product packaging. The Department of Health will enforce the rule, with penalties of $500 for a first offense, $1,000 for a second, and $2,000 for subsequent violations. The goal is to help consumers with allergies or sensitivities safely identify and avoid potentially harmful ingredients in medications.

Topics ✓ HealthcareSupports HealthcareMandates allergen labeling on drugs to prevent adverse reactions, directly protecting patient safety and rights in medication use.90% confidence

Track

in committee · New Jersey · General Assembly Jan 13, 2026

A 3723: Requires licensed health care professionals providing prenatal care to offer and screen, upon request, pregnant patients with history of depression for postpartum depression.

This New Jersey bill (A 3723) requires licensed healthcare providers offering prenatal care to offer and provide, upon request, a screening for postpartum depression to pregnant patients with a history of depression. It directly affects pregnant individuals with prior depression diagnoses by adding a specific screening step during prenatal visits. Key provisions include mandating education about postpartum depression for patients and families, requiring screenings before birthing facility discharge and at early postnatal visits, and involving partners/family in education and support. The bill amends existing law (P.L.2000, c.167) to expand screening requirements beyond current universal postnatal checks.

Topics ✓ HealthcareSupports HealthcareMandates mental health screening for postpartum depression during prenatal visits, expanding access to early intervention for at-risk patients and strengthening maternal mental health services.92% confidence

Sub-Topics Women's Health

Track

in committee · New Jersey · General Assembly Jan 13, 2026

A 2445: Allows gross income tax deductions totaling $300,000 over five taxable years for certain primary care physicians.

This New Jersey bill allows qualified primary care physicians - specializing in family medicine, internal medicine, pediatrics, or obstetrics/gynecology - to deduct up to $300,000 from their state income tax over five years. The deduction begins at $100,000 in the first year and decreases by $20,000 annually ($80,000, $60,000, $40,000, $20,000) for the next four years. To qualify, physicians must maintain a New Jersey practice for all five years; failure to do so requires repayment of the full deduction amount. The policy aims to address statewide primary care physician shortages by reducing tax liability for qualifying doctors.

Topics ✓ Budget & TaxesSupports Budget & TaxesProvides tax deduction for qualifying physicians, reducing taxable income as targeted tax relief under state tax policy.95% confidence ✓ HealthcareSupports HealthcareTax deduction for primary care physicians aims to retain providers in NJ, improving access to essential healthcare services through workforce incentives.90% confidence

Sub-Topics Income Tax Primary Care

Track

in committee · New Jersey · General Assembly Jan 13, 2026

A 3673: Increases hourly limit of reimbursable personal care assistant services under NJ WorkAbility Program.

This bill increases the maximum weekly reimbursement limit for personal care assistant services under New Jersey's WorkAbility Program from 40 hours to 112 hours per calendar week. It directly affects employed, permanently disabled New Jersey residents who qualify for the program by meeting income thresholds (under 250% of federal poverty level for earned income) and having a disability certified by Social Security or the state. The key change allows these individuals to receive significantly more hours of covered personal care support through existing Medicaid contracts managed by the state. This adjustment aligns with federal Medicaid program requirements and aims to provide greater flexibility for participants in the WorkAbility Program.

Topics ✓ HealthcareSupports HealthcareIncreases reimbursement limit for personal care assistant services, expanding healthcare coverage and funding for disabled individuals' essential health needs.95% confidence ✓ Labor & EmploymentSupports Labor & EmploymentIncreases reimbursement for personal care services, directly enabling disabled workers to maintain employment by covering 112 weekly hours (vs 40), strengthening employment support for a vulnerable workforce.95% confidence

Sub-Topics Medicaid

Track

in committee · New Jersey · General Assembly Jan 13, 2026

A 3365: Makes supplemental appropriation of $500,000 to DOH for Huntington's Disease Grant Program.

This bill appropriates an additional $500,000 from the General Fund to New Jersey's Department of Health (DOH) for the Huntington's Disease Grant Program, increasing its total funding for fiscal year 2025 to $701,000 (from an estimated $201,000). The funds will support grants to New Jersey-based institutions of higher education, non-profits, and research organizations to provide pre-symptomatic testing, neurology/psychiatry services, treatment, disease management, and counseling. It directly affects approximately 900-1,200 New Jersey residents living with Huntington's disease and about 7,000 at-risk individuals. Huntington's disease is a fatal, inherited condition causing progressive neurological decline without a cure.

Topics ✓ Budget & TaxesSupports Budget & TaxesBill allocates $500,000 supplemental appropriation from General Fund to DOH for Huntington's Disease program, increasing FY2025 funding to $701,000, directly advancing state budget allocation for essential health services.95% confidence ✓ HealthcareSupports HealthcareIncreases funding for Huntington's Disease grant program, supporting patient services including testing, treatment, and counseling under healthcare.95% confidence

Sub-Topics Appropriations State Budget

Track

in committee · New Jersey · General Assembly Feb 19, 2026

A 4240: Requires DOH to inspect reports of mold infestation in health care facilities.

This bill requires New Jersey's Department of Health (DOH) to inspect reports of mold infestation in healthcare facilities within six months of the law taking effect. It also mandates the DOH to develop guidelines for preventing or removing mold in these facilities within the same timeframe. The law defines "mold" broadly to include specific types commonly found in water-damaged building materials, such as Stachybotrys Chartarum. Healthcare facilities regulated by the DOH under Title 26 of New Jersey law would be directly affected by these new inspection and prevention requirements.

Topics ✓ HealthcareSupports HealthcareMandates DOH inspections and mold prevention guidelines in healthcare facilities, directly enhancing facility safety and patient protection per healthcare topic definition.95% confidence

Track

in committee · New Jersey · General Assembly Jan 13, 2026

A 529: Repeals "Medical Aid in Dying for the Terminally Ill Act."

This bill repeals New Jersey's 2019 "Medical Aid in Dying for the Terminally Ill Act" (P.L.2019, c.59), which allowed terminally ill patients to access physician-assisted medication under strict safeguards. By repealing sections 1-26 of that law, the bill removes the legal exception that previously protected healthcare providers and patients from criminal prosecution under N.J.S.2C:11-6 (aiding suicide) when following the act's procedures. The repeal means aiding suicide would again be punishable as a crime under state law, directly affecting terminally ill patients who could previously seek this option and healthcare providers who followed the repealed act's requirements. The change takes immediate effect upon enactment.

Topics ✗ Criminal JusticeOpposes Criminal JusticeRepeals exception protecting physician-assisted dying from aiding suicide prosecution, expanding criminalization under N.J.S.2C:11-6 and removing legal safeguards.90% confidence ✗ HealthcareOpposes HealthcareRepeals law allowing physician-assisted dying, restricting patient access to end-of-life care under New Jersey's medical aid in dying act.95% confidence

Track